Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas(†)

The objective of this study was to evaluate whether longitudinal levels of serum YKL-40 correlate with disease status or survival in adults with gliomas. Patients with histologically confirmed gliomas were eligible for this longitudinal study. Serum samples were collected prospectively and concurren...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Iwamoto, Fabio M., Hottinger, Andreas F., Karimi, Sasan, Riedel, Elyn, Dantis, Jocelynn, Jahdi, Maryam, Panageas, Katherine S., Lassman, Andrew B., Abrey, Lauren E., Fleisher, Martin, DeAngelis, Lisa M., Holland, Eric C., Hormigo, Adília
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2011
Aiheet:
Clinical Investigations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3199155/
https://ncbi.nlm.nih.gov/pubmed/21831900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nor117
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia